IVAC-all-1: interim analysis of a phase I/II clinical study on personalized peptide vaccination based on patient-individual tumor-specific variants in relapsed pediatric acute lymphoblastic leukemia

DSpace Repository

IVAC-all-1: interim analysis of a phase I/II clinical study on personalized peptide vaccination based on patient-individual tumor-specific variants in relapsed pediatric acute lymphoblastic leukemia

Author: Rabsteyn, Armin; Mohr, Christopher; Witt, Olaf; Meisel, Roland; Chen-Santel, Christiane; Feuchtinger, Tobias; Schroeder, Christopher M; Matthes, Jakob; Casadei, Nicolas; Hundsdoerfer, Patrick; Schulte, Johannes; Milde, Till; Stevanovic, Stefan; Riess, Olaf; Kohlbacher, Oliver; Rammensee, Hans-Georg; Pfister, Stefan; Lang, Peter; Handgretinger, Rupert
Tübinger Autor(en):
Rabsteyn, Armin
Mohr, Christopher
Matthes, Jakob
Casadei, Nicolas
Kohlbacher, Oliver
Rammensee, Hans-Georg
Lang, Peter
Schroeder, Christopher
Stevanović, Stefan
Rieß, Olaf
Handgretinger, Rupert
Published in: Bone Marrow Transplantation (2019), Bd. 54, S. 518-519
Language: English
Full text: https://doi.org/10.1038/s41409-019-0559-4
DDC Classifikation: 004 - Data processing and computer science
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)